ATE497786T1 - Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen - Google Patents
Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellenInfo
- Publication number
- ATE497786T1 ATE497786T1 AT09008139T AT09008139T ATE497786T1 AT E497786 T1 ATE497786 T1 AT E497786T1 AT 09008139 T AT09008139 T AT 09008139T AT 09008139 T AT09008139 T AT 09008139T AT E497786 T1 ATE497786 T1 AT E497786T1
- Authority
- AT
- Austria
- Prior art keywords
- kits
- delivery
- compositions
- cells
- increase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/889,355 US7002027B1 (en) | 1996-01-08 | 1997-07-08 | Compositions and methods for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE497786T1 true ATE497786T1 (de) | 2011-02-15 |
Family
ID=25394956
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09008139T ATE497786T1 (de) | 1997-07-08 | 1998-07-08 | Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen |
AT98934359T ATE434448T1 (de) | 1997-07-08 | 1998-07-08 | Zusammensetzungen und verfahren zur verstärkung der verabreichung von therapeutischen mitteln in zellen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98934359T ATE434448T1 (de) | 1997-07-08 | 1998-07-08 | Zusammensetzungen und verfahren zur verstärkung der verabreichung von therapeutischen mitteln in zellen |
Country Status (21)
Country | Link |
---|---|
US (3) | US7002027B1 (de) |
EP (2) | EP2106807B1 (de) |
JP (2) | JP4460148B2 (de) |
KR (1) | KR100691572B1 (de) |
AR (1) | AR016312A1 (de) |
AT (2) | ATE497786T1 (de) |
AU (1) | AU774338B2 (de) |
CA (1) | CA2294709C (de) |
CY (1) | CY1109367T1 (de) |
DE (2) | DE69842133D1 (de) |
DK (1) | DK1011733T3 (de) |
ES (2) | ES2328094T3 (de) |
HK (2) | HK1028961A1 (de) |
HU (1) | HUP0002683A3 (de) |
IL (1) | IL133929A0 (de) |
MY (1) | MY138257A (de) |
NZ (1) | NZ502060A (de) |
PT (1) | PT1011733E (de) |
TW (1) | TW490306B (de) |
WO (1) | WO1999002191A1 (de) |
ZA (1) | ZA986003B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6392069B2 (en) * | 1996-01-08 | 2002-05-21 | Canji, Inc. | Compositions for enhancing delivery of nucleic acids to cells |
US7002027B1 (en) * | 1996-01-08 | 2006-02-21 | Canji, Inc. | Compositions and methods for therapeutic use |
US20040014709A1 (en) * | 1996-01-08 | 2004-01-22 | Canji, Inc. | Methods and compositions for interferon therapy |
US5789244A (en) * | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
AU768542C (en) | 1998-04-08 | 2004-06-17 | Celltech R & D Limited | Lipids |
SI1456377T1 (sl) * | 2001-12-20 | 2019-09-30 | Merck Sharp & Dohme Corp. | Sestavki SYN3 in postopki |
NZ543970A (en) * | 2003-06-04 | 2008-09-26 | Canji Inc | Methods and compositions for interferon therapy |
EP1628624A2 (de) * | 2003-06-04 | 2006-03-01 | CANJI, Inc. | Verfahren und zusammensetzungen für die interferon-therapie |
US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
US7691822B2 (en) * | 2003-12-10 | 2010-04-06 | Canji, Inc. | Methods and compositions for treatment of interferon-resistant tumors |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US8716021B2 (en) * | 2005-09-07 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of replicators to prevent gene silencing |
WO2009136396A2 (en) * | 2008-05-05 | 2009-11-12 | Tiltan Pharma Ltd. | Sulfobetaines for therapy |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
EP2488210A4 (de) | 2009-10-12 | 2014-04-30 | Smith Holdings Llc | Verfahren und zusammensetzungen zur modulation der genexpression mit in-vivo oder in-vitro verabreichten arzneistoffen auf oligonukleotidbasis |
US20120147800A1 (en) * | 2010-12-10 | 2012-06-14 | Minyoung Park | Power management in a wireless network having stations with different power capabilities |
US20120237492A1 (en) | 2011-02-18 | 2012-09-20 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
US10492104B2 (en) * | 2016-03-10 | 2019-11-26 | Cable Television Laboratories, Inc. | Latency reduction in wireless service |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554386A (en) | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US6207454B1 (en) | 1989-10-16 | 2001-03-27 | Amgen Inc. | Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
US5120316A (en) | 1990-09-28 | 1992-06-09 | Akzo N.V. | Urethral catheter and catheterization process |
WO1992006180A1 (en) | 1990-10-01 | 1992-04-16 | University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
DE59108326D1 (de) * | 1990-12-06 | 1996-12-12 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindung als Arzneimittel |
WO1993000052A1 (en) | 1991-06-28 | 1993-01-07 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
WO1993002556A1 (en) | 1991-07-26 | 1993-02-18 | University Of Rochester | Cancer therapy utilizing malignant cells |
US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5521291A (en) | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US6013638A (en) | 1991-10-02 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
US5795870A (en) * | 1991-12-13 | 1998-08-18 | Trustees Of Princeton University | Compositions and methods for cell transformation |
AU3434393A (en) | 1992-01-17 | 1993-08-03 | Regents Of The University Of Michigan, The | Targeted virus |
US5602023A (en) | 1992-03-24 | 1997-02-11 | Csatary; Laszlo K. | Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same |
AU682308C (en) | 1992-04-03 | 2006-08-17 | Regents Of The University Of California, The | Self-assembling polynucleotide delivery system |
CA2133411A1 (en) | 1992-04-03 | 1993-10-14 | Alexander T. YOUNG | Gene therapy using targeted viral vectors |
US5334761A (en) | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
US5656609A (en) | 1992-09-24 | 1997-08-12 | University Of Connecticut | Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine |
WO1994006923A1 (en) | 1992-09-24 | 1994-03-31 | The University Of Connecticut | Modification of a virus to redirect infectivity and enhance targeted delivery of polynucleotides to cells |
US5346701A (en) | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
US5578475A (en) | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
US5631236A (en) | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
US5804566A (en) * | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
JPH07109983A (ja) | 1993-10-13 | 1995-04-25 | Nippondenso Co Ltd | スクロール型圧縮機 |
EP0723440B1 (de) | 1993-10-15 | 2003-01-02 | Cytrx Corporation | Therapeutische abgabesysteme und verfahren für ihre verwendung |
US6210939B1 (en) | 1993-10-25 | 2001-04-03 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
ATE314482T1 (de) | 1993-10-25 | 2006-01-15 | Canji Inc | Rekombinante adenoviren-vektor und verfahren zur verwendung |
US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
US5552309A (en) | 1994-09-30 | 1996-09-03 | Indiana University Foundation | Use of polyols for improving the introduction of genetic material into cells |
US7163925B1 (en) | 1995-07-17 | 2007-01-16 | Board Of Regents, The University Of Texas System | p16 expression constructs and their application in cancer therapy |
WO1997005209A1 (en) * | 1995-07-28 | 1997-02-13 | Kohne David E | Method for enhancing chemiluminescence |
US20040014709A1 (en) | 1996-01-08 | 2004-01-22 | Canji, Inc. | Methods and compositions for interferon therapy |
US7002027B1 (en) | 1996-01-08 | 2006-02-21 | Canji, Inc. | Compositions and methods for therapeutic use |
US5789244A (en) | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
US6392069B2 (en) | 1996-01-08 | 2002-05-21 | Canji, Inc. | Compositions for enhancing delivery of nucleic acids to cells |
US5671110A (en) | 1996-01-23 | 1997-09-23 | Oneac Corporation | Ground skew protection method and apparatus |
US6283940B1 (en) * | 1997-08-29 | 2001-09-04 | S. Grant Mulholland | Catheter |
US6938069B1 (en) * | 2000-03-18 | 2005-08-30 | Computing Services Support Solutions | Electronic meeting center |
SI1456377T1 (sl) | 2001-12-20 | 2019-09-30 | Merck Sharp & Dohme Corp. | Sestavki SYN3 in postopki |
KR100499787B1 (ko) | 2002-11-29 | 2005-07-07 | 인티그런트 테크놀로지즈(주) | 스위치 모드 동작을 하는 선형성이 우수한 광대역 가변이득 증폭기 |
EP1628624A2 (de) | 2003-06-04 | 2006-03-01 | CANJI, Inc. | Verfahren und zusammensetzungen für die interferon-therapie |
NZ543970A (en) | 2003-06-04 | 2008-09-26 | Canji Inc | Methods and compositions for interferon therapy |
WO2004108898A2 (en) | 2003-06-04 | 2004-12-16 | Canji, Inc. | Transfection agents |
US7691822B2 (en) | 2003-12-10 | 2010-04-06 | Canji, Inc. | Methods and compositions for treatment of interferon-resistant tumors |
-
1997
- 1997-07-08 US US08/889,355 patent/US7002027B1/en not_active Expired - Fee Related
-
1998
- 1998-07-07 MY MYPI98003070A patent/MY138257A/en unknown
- 1998-07-07 ZA ZA986003A patent/ZA986003B/xx unknown
- 1998-07-08 EP EP09008139A patent/EP2106807B1/de not_active Expired - Lifetime
- 1998-07-08 DE DE69842133T patent/DE69842133D1/de not_active Expired - Lifetime
- 1998-07-08 IL IL13392998A patent/IL133929A0/xx unknown
- 1998-07-08 AR ARP980103311A patent/AR016312A1/es unknown
- 1998-07-08 NZ NZ502060A patent/NZ502060A/en not_active IP Right Cessation
- 1998-07-08 DK DK98934359T patent/DK1011733T3/da active
- 1998-07-08 AU AU83901/98A patent/AU774338B2/en not_active Ceased
- 1998-07-08 KR KR1020007000178A patent/KR100691572B1/ko not_active IP Right Cessation
- 1998-07-08 AT AT09008139T patent/ATE497786T1/de not_active IP Right Cessation
- 1998-07-08 AT AT98934359T patent/ATE434448T1/de active
- 1998-07-08 CA CA2294709A patent/CA2294709C/en not_active Expired - Fee Related
- 1998-07-08 ES ES98934359T patent/ES2328094T3/es not_active Expired - Lifetime
- 1998-07-08 PT PT98934359T patent/PT1011733E/pt unknown
- 1998-07-08 HU HU0002683A patent/HUP0002683A3/hu unknown
- 1998-07-08 DE DE69840932T patent/DE69840932D1/de not_active Expired - Lifetime
- 1998-07-08 EP EP98934359A patent/EP1011733B1/de not_active Expired - Lifetime
- 1998-07-08 WO PCT/US1998/014241 patent/WO1999002191A1/en not_active Application Discontinuation
- 1998-07-08 JP JP2000501781A patent/JP4460148B2/ja not_active Expired - Fee Related
- 1998-07-08 ES ES09008139T patent/ES2362027T3/es not_active Expired - Lifetime
-
1999
- 1999-01-11 TW TW087111049A patent/TW490306B/zh not_active IP Right Cessation
-
2000
- 2000-12-21 HK HK00108262.4A patent/HK1028961A1/xx not_active IP Right Cessation
-
2006
- 2006-02-21 US US11/359,997 patent/US7538093B2/en not_active Expired - Fee Related
-
2009
- 2009-04-13 US US12/422,807 patent/US8022044B2/en not_active Expired - Fee Related
- 2009-09-15 CY CY20091100949T patent/CY1109367T1/el unknown
- 2009-12-24 JP JP2009293390A patent/JP2010070565A/ja not_active Withdrawn
-
2010
- 2010-02-04 HK HK10101219.1A patent/HK1134025A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE497786T1 (de) | Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen | |
ATE268597T1 (de) | Verfahren und zusammensetzungen zur erhöhung der anzahl weisser blutzellen | |
ID22970A (id) | Komposisi perekat | |
ID22878A (id) | Komposisi aktif secara terapi | |
BR9800344A (pt) | Composição de vidro e utilização das composições de vidro | |
DE69836008D1 (de) | Zusammensetzung und behandlungsmittel | |
PT900225E (pt) | Alquil-4-silil-fenois e esteres destes como agentes antiateroscleroticos | |
FI990171A (fi) | Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi | |
DE69715801T2 (de) | Granuläre Zusammensetzungen von E-pthalimido-Peroxyhexansäure | |
DE69812784D1 (de) | Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten | |
DE69841984D1 (de) | Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen | |
DE59806485D1 (de) | Herstellung von Ascorbylmonophosphaten | |
DE59915061D1 (de) | Herstellung von strukturierten elektroden | |
EE04055B1 (et) | Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine | |
DE69840752D1 (de) | Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen | |
ATE308365T1 (de) | Zusammensetzungen zur oralen verabreichung von taxanen und deren verwendung | |
PT928197E (pt) | Utilizacao de proteinas como agentes contra doencas de natureza autoimunitaria | |
EE04870B1 (et) | Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid | |
ID24306A (id) | Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori | |
ID22378A (id) | Komposisi untuk mencegah dan mengobati penyakit gusi | |
DE59812720D1 (de) | Verwendung von phytostenol enthaltender wirkstoffmischungen zur herstellung von hypocholesterinämischen mitteln | |
PT1230227E (pt) | Sulamatos de benzole e benzotiazole e sua utilizacao como inibidores de sulfatase | |
DE69821227D1 (de) | Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen | |
DE59502325D1 (de) | Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung | |
IT1292103B1 (it) | Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |